User Reviews for Stivarga
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
|Colorectal Cancer||2 reviews||19 medications|
|Gastrointestinal Stromal Tumor||1 review||3 medications|
|Summary of Stivarga reviews||5.5||3 reviews|
Reviews for Stivarga
For Colorectal Cancer "Have taken this medication for over a year. Carcinoembryonic antigen (CEA) well within normal range. Slightly elevated bilirubin. Only side effects are mild to moderate hand foot syndrome, some fatigue and nosebleeds due to low platelets. It is important to note that I have never done IV chemo, so my results may be different from others."
Bvsdslp (taken for 1 to 2 years) November 7, 2017
5 users found this comment helpful.
For Colorectal Cancer "I am writing this as a data point for those who may be considering this drug. My mother was recently put on this and it was literally the worst drug she's ever taken in her 6 year journey battling cancer. I read the reviews and begged her not to take it, but she went through it anyway. The drug caused her to be lethargic to the point where she could not move, she had a severe loss of appetite, she broke out in hives, she lost a significant amount of weight and could barely walk/clothe herself. She literally could not function. She took it for two weeks and by the end of it was so incoherent and weak that she collapsed inside of our home. And this was from taking 2 pills one week, 3 pills the next."
Cancerfreakingsucks July 20, 2017
6 users found this comment helpful.
For Gastrointestinal Stromal Tumor "Only side effects and no result"
Harish689 September 9, 2015
8 users found this comment helpful.
Learn more about
Mayo Clinic Reference
More about Stivarga (regorafenib)
- Stivarga Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: multikinase inhibitors